GE Healthcare has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its Discovery MI PET/CT scanner.
First debuted at the 2016 Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting in San Diego, Discovery MI features GE's LightBurst digital detector and the firm's time-of-flight and Q.Clear image reconstruction technology. The scanner also includes low-yield tracer capability with protocols that can lower dose by up to 50%, GE said.
In addition, Discovery MI utilizes GE's ASIR-V adaptive statistical iterative reconstruction (ASIR) techniques, as well as the firm's metal artifact reduction software.
